Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Santarus, Inc.    

SANTARUS, INC.
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets
Latest news on SANTARUS, INC.
2013SANTARUS, INC. : Relocation Plans, Patient Enrollment, Management Appointments, ..
PR
2013SANTARUS, INC. : Santarus Announces Availability of Amended Tender Offer Materia..
BU
2013SANTARUS, INC. : Santarus Initiates Phase IIa Study with SAN-300 in Patients wit..
BU
2013HBK INVESTMENTS LP 3Q 13F : Largest Purchases -2-
DJ
2013HBK INVESTMENTS LP 3Q 13F : Largest Purchases
DJ
2013HBK INVESTMENTS LP 3Q 13F : Holdings As Of Sep 30 -2-
DJ
2013HBK INVESTMENTS LP 3Q 13F : Holdings As Of Sep 30
DJ
2013HIGHBRIDGE CAPITAL MANAGEMENT 3Q 13F : Largest -2-
DJ
2013HIGHBRIDGE CAPITAL MANAGEMENT 3Q 13F : Largest Purchases
DJ
2013KINGDON CAPITAL MANAGEMENT 3Q 13F : Largest Eliminations
DJ
2013KINGDON CAPITAL MANAGEMENT 3Q 13F : Holdings As Of -2-
DJ
2013KINGDON CAPITAL MANAGEMENT 3Q 13F : Holdings As Of Sep 30
DJ
2013FIDELITY MANAGEMENT & RESEARCH CO. 3 : -2-
DJ
2013FIDELITY MANAGEMENT & RESEARCH CO. 3 : Largest Purchases
DJ
2013MILLENNIUM MANAGEMENT 3Q 13F : Largest Sales -2-
DJ
2013MILLENNIUM MANAGEMENT 3Q 13F : Largest Sales
DJ
2013SANTARUS, INC. : Morgan & Morgan Announces the Investigation of Santarus, Inc.
PR
2013SANTARUS, INC. : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigati..
BU
2013SANTARUS, INC. : Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc.
PR
2013SANTARUS, INC. : Harwood Feffer LLP Announces Investigation of Santarus, Inc.
PR
2013SANTARUS, INC. : and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, ..
PR
2013Dow, S&P 500 end higher for fifth straight week; financials lead
RE
2013SANTARUS, INC. : Law Firm Kirby McInerney LLP Investigating Potential Claims on ..
BU
2013SANTARUS, INC. : Law Offices of Howard G. Smith Announces Investigation of Santa..
BU
2013SANTARUS, INC. : SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That ..
PR
2013SANTARUS, INC. : Wolf Haldenstein Announces Investigation of Acquisition of Sant..
BU
2013SANTARUS, INC. : Santarus Shareholder Alert: Former SEC Attorney Willie Briscoe ..
BU
2013SANTARUS, INC. : Investor Alert: Holzer Holzer & Fistel, LLC Announces Investiga..
BU
2013SANTARUS, INC. : SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the ..
BU
2013SANTARUS, INC. : Finkelstein Thompson LLP Announces Investigation of Santarus, I..
BU
2013SANTARUS, INC. : Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Inv..
BU
2013SANTARUS, INC. : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigati..
BU
2013SANTARUS, INC. : Shareholder Alert: Bernstein Liebhard LLP Announces Investigati..
PR
2013SANTARUS, INC. : Law Firm Brower Piven Announces Investigation of Santarus, Inc...
BU
2013SANTARUS, INC. : LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of C..
BU
2013SANTARUS, INC. : Santarus and Pharming Announce New Data from Open-Label Repeat ..
PU
2013SANTARUS, INC. : Salix bolsters gastro drug line-up with $2.6 billion Santarus b..
RE
2013SALIX PHARMACEUTICALS, LTD. : Salix to Pay $2.15 Billion to Buy Santarus
DJ
2013SANTARUS, INC. : The Law Firm of Wohl & Fruchter is Investigating the Acquisitio..
BU
2013SANTARUS, INC. : LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of C..
BU
2013SANTARUS, INC. : Block & Leviton LLP Investigates Santarus, Inc. for Possible Br..
PR
2013SANTARUS, INC. : Investor Alert - Buyout Of Santarus - Shareholder Rights Law Fi..
PR
2013SANTARUS, INC. : Santarus Reports Third Quarter 2013 Financial Results
BU
2013SANTARUS, INC. : Salix Pharmaceuticals to Acquire Santarus
BU
2013SANTARUS, INC. : Acquisitions, Financial Results, Clinical Trial Applications, a..
PR
2013SANTARUS, INC. : Santarus to Hold Third Quarter 2013 Financial Results Conferenc..
BU
2013SANTARUS, INC. : Santarus Announces Presentation of SAN-300 Phase I Data at 2013..
BU
2013SANTARUS, INC. : Santarus Announces Presentation of Phase III Data for Rifamycin..
BU
2013SANTARUS, INC. : Pre-Market Review: Isis Pharmaceuticals Inc., Community Health ..
PR
2013SANTARUS, INC. : Santarus to Present at September Investment Conferences
BU
2013U.S. HOT STOCK FUTURES : Hot stocks to watch
DJ
2013SANTARUS, INC. : Pre-Market Analysis: Community Health Systems, Isis Pharmaceuti..
PR
2013SANTARUS, INC. : Santarus Reports Second Quarter 2013 Financial Results
BU
2013SANTARUS, INC. : Santarus to Hold Second Quarter 2013 Financial Results Conferen..
BU
2013SANTARUS, INC. : Santarus Completes Patient Enrollment in CONTRIBUTE Study with ..
BU
2013SANTARUS, INC. : Santarus to Present at JMP Securities Healthcare Conference
BU
2013SANTARUS, INC. : Santarus and Pharming Announce Poster Presentation of Pivotal C..
PU
2013SANTARUS, INC. : Data Presentations, Orphan Drug Designations, FDA Applications ..
PR
2013SANTARUS, INC. : Santarus and VeroScience Announce CYCLOSET (bromocriptine mesyl..
BU
2013SANTARUS, INC. : Santarus and Pharming Announce FDA Acceptance for Review of RUC..
BU
2013SANTARUS, INC. : Santarus President & CEO Gerald Proehl Honored as San Diego Ern..
BU
2013SANTARUS, INC. : Santarus Announces UCERIS (budesonide) Poster Presentations at ..
BU
2013SANTARUS, INC. : Santarus Announces Exercise in Full of Option to Purchase Addit..
BU
2013SANTARUS, INC. : Santarus Announces Pricing of Secondary Common Stock Offering b..
BU
2013SANTARUS, INC. : Santarus Announces Launch of a Proposed Secondary Common Stock ..
BU
2013SANTARUS, INC. : Santarus Reports First Quarter 2013 Financial Results
BU
2013SANTARUS, INC. : Santarus to Present at May and June Investment Conferences
BU
2013SANTARUS, INC. : CYCLOSET (bromocriptine mesylate) Included in American Associat..
BU
2013SANTARUS, INC. : Santarus to Hold First Quarter 2013 Financial Results Conferenc..
BU
2013SANTARUS, INC. : Santarus to Host Investor and Analyst Day on April 11, 2013
PU
2013SANTARUS, INC. : Before the Bell Scans of MannKind, Ariad Pharma, ZIOPHARM Oncol..
PR
2013SANTARUS, INC. : Santarus Announces Publication in Gut of Results from UCERIS (b..
BU
2013SANTARUS, INC. : Santarus and VeroScience Announce Publication of AACE Expert Pa..
BU
2013MARKET SNAPSHOT : U.S. Stocks Rally To Lift Dow To New Heights
DJ
2013SANTARUS, INC. : Santarus Reports Fourth Quarter and Full Year 2012 Financial Re..
BU
1  2  3Next
Income Statement Evolution
Sector and Competitors
1st jan.Capitalization (M$)
SANTARUS, INC.0
BIOGEN-7.06%61 749
CSL LIMITED7.22%55 758
ALEXION PHARMACEUTICALS3.02%26 706
GRIFOLS SA-4.40%18 322
BIOMARIN PHARMACEUTICAL-5.19%14 924